Pirarubicin is an anthracycline compound and an analogue of doxorubicin. It functions by intercalating into DNA and interacting with topoisomerase II, thereby inhibiting DNA replication and repair as well as RNA and protein synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 72496-41-4
Doxorubicin
pharmaceutical raw material
Doxorubicin hydrochloride
pharmaceutical raw material
Epirubicin hydrochloride
pharmaceutical raw material
Felodipine
pharmaceutical raw material
Phenyl-(2-pyridyl)acetamide
pharmaceutical raw material
Ceftazidime
pharmaceutical raw material
Gadoteric acid
pharmaceutical raw material
(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2R)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
KMSKQZKKOZQFFG-YXRRJAAWSA-N
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O[C@@H]6CCCCO6